Insider Trading & Ownership of Roy D. Baynes

Location
San Diego, CA
Summary
The estimated net worth of Roy D. Baynes is at least $5,468,513 dollars as of 15 May 2026. Roy D. Baynes is the Director of Natera, Inc. and owns shares of Natera, Inc. (NTRA) stock worth about $3.7M. Roy D. Baynes is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $1.75M. Roy D. Baynes is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $16.9K.
Signature
/s/ Daniel Burbach, as Attorney-in-Fact for Roy D. Baynes
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Roy D. Baynes and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Roy D. Baynes has 6 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $5,468,513.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Natera, Inc. ($3,702,216).
  • Past-year value change for that position: -$2,809,689.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Roy D. Baynes

NTRA Forms 3/4/5

Natera, Inc.

Relationship
Director
Holdings value
$3,702,216
Past year net change
-$2,809,689
Change %
-43%
Report period
24 Apr 2026

Insider Transactions Reported by Roy D. Baynes:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .